Scientific Committee

Scientific Committee

Ontwerp zonder titel (38)

Natalie Alepeé

_GF_3487-53_hi

Anax Falcão de Oliveira

Anax Falcão de Oliveira holds a PhD in Toxicology from the University of São Paulo, Brazil, and has extensive experience evaluating safety of pharmaceuticals, cosmetics, and medical devices. Throughout his career he has supported the development, implementation, and advocated for the regulatory uptake of NAMs to enhance chemical safety assessments. He has actively contributed to several industry and regulatory groups around NAMs and chemical safety, and is part of the Board of Directors of the Brazilian Society of Toxicology.
Image Kelen Fabiola Arroteia JPEG

Kelen Fabíola Arroteia

Kelen is Biologist and holds a Master's and a PhD degree in Cellular Biology at the State University of Campinas, Brazil. With extensive experience in cellular biology, she has been working at Natura since 2006, spearheading the development of substitutive methods for animal testing. As manager of the Pre-Clinical Safety and Efficacy Center, she currently leads the application of cutting-edge methodologies for both safety assessment and efficacy investigation of botanical ingredients developed for cosmetic purposes.
photo 2

Marcelo Asprea

Marcelo Asprea is Head of biothery and experimental surgery Hospital de Pediatría Samic Prof. Dr Juan P.Garrahan, Buenos Aires, Argentina. He is a veterinarian graduated from the Faculty of Veterinary Sciences University of Buenos Aires; Head of biothery and experimental surgery Hospital de Pediatria. Prof Dr Juan P Garrahan; Veterinary anesthesiology and laboratory animals specialist both granted by the professional council of veterinary doctors. Former President of the Argentine Association of Science and Technology of Laboratory Animals (AACyTAL) 2013-2018 Former President of The Federation of South American Societies for Laboratory Animal Sciences (FESSACAL) 2020-2023 and 2023-2026.
Joao_low-2

João Barroso

João Barroso works at the European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) of the European Commission's Joint Research Centre (JRC). He holds a doctoral degree in Biochemistry and Molecular Biology since 2005. He coordinates and conducts scientific and policy support activities in the area of non-animal approaches, including the identification and validation of promising approaches for regulatory and biomedical applications and their translation into EU legislation and international standards.
2017-09-20-egfa-0182

Luísa Ferreira Bastos

Dr Luísa Bastos leads the animals in science programme at Eurogroup for Animals, where she represents the Pan-European animal protection network in institutional and scientific fora. Her work aims at strengthening the collaboration and coordination among stakeholders to accelerate the transition to non-animal science. She holds a doctorate in biomedical engineering. In her earlier research positions, she worked with cross-sectorial and interdisciplinary teams focused on the development and marketing of medical technologies.
Helena Kandarova 43

Helena Kanďárová

Dr. Helena Kandarova, Director of the Institute of Experimental Pharmacology and Toxicology at the Slovak Academy of Sciences, focuses on developing alternative methods for topical toxicity testing. She co-authored several OECD, ICH, and ISO guidelines. Before academia, she led MatTek In Vitro Life Science Laboratories in the EU. Dr. Kandarova has over 80 publications and serves on various international boards, including OECD expert groups. She has been President of the European Society for Toxicology In Vitro (ESTIV) since 2020.
sandra55

Sandra Coecke

Dr. Sandra Coecke, a senior scientist and policy advisor at the European Commission's Joint Research Centre, leads the Emerging Health Threats & One Health Approach team. Holding a PhD in Biomedical Sciences, her work integrates science, policy, and innovation in digital health and EU health crisis resilience. She has advanced EU strategies against diseases and environmental risks, specializing in in vitro and in silico methods, model sharing, scientific quality, open science, and Nagoya Protocol ethics.
Foto Bruno

Bruno Dallagiovanna

Bruno Dallagiovanna. Senior researcher from Fiocruz (Brazil). Head of the Basic Stem Cell Research Group of the Carlos Chagas Institute, Curitiba, Brazil. Molecular and cellular biologist currently working in the use of human stem cells in MPS for toxicity analysis and disease modelling.
Barney Reed

Barney Reed

Barney Reed is a senior Science and Policy Manager RSPCA, UK. Works in the UK and internationally to support the transition to non-animal methodologies, promotes the 3Rs and effective processes of ethical review and regulation. Member of various Expert Working Groups established by the European Commission to help Member States implement the EU Directive on laboratory animals. Past appointed member of the Animals in Science Committee providing expert advice to UK Government. Has served on IACUC equivalent bodies of eight research establishments across academia and industry.
Suzanne_Fitzpatrick_01-199x300

Suzanne Fitzpatrick

Dr. Suzanne Fitzpatrick is the Senior Advisor for Toxicology at the US FDA Foods Program, a board-certified toxicologist, and chairs the FDA’s Alternative Methods Work Group. She helped develop the FDA DARPA NCATS program on Organs on a Chip and continues work in this area. She co-chairs the International Working Group on New Approach Methods for Food Safety and is the FDA lead for ICCVAM and Tox 21. She earned her PhD from Georgetown University.
A.Gourmelon_2

Anne Gourmelon

Anne Gourmelon is Principal Administrator of the OECD Test Guidelines Programme since 2013. Before that she was project manager working on test methods validation for endocrine disrupters for the aquatic environment. She has a masters degree in environmental sciences from the University of Wageningen, Netherlands. Her work consists in coordinating collaborative and multi-disciplinary projects at the OECD, supported by a team of dedicated project managers and a vast network of regulators and subject matter experts.
MAC_9336

Chrisna Gouws

Chrisna Gouws obtained a PhD (Biochemistry) degree at the North-West University in 2012, and has been a researcher at the Centre of Excellence for Pharmaceutical Science (PharmaCen™) since. Her research activities focus on developing new cell-based in vitro models for applications in drug research, including medicinal plants for cancer treatment. She is a board member of the International Microphysiological Systems Society, and the Executive Committee Chair for the Society for Advanced Cell Culture Modelling for Africa.
IMG_20240419_090122848~2

Laura Gutierrez

Laura Gutierrez is director of the Alternative Methods Laboratory at EBAL Platform – LMA EBAL. CONICET researcher at the Institute of Pharmacology of the Faculty of Medicine of the University of Buenos Aires, Argentina. Bachelor's and Ph.D. in Biological Sciences from the University of Buenos Aires. Working to disseminate the use and acceptance of alternative methods in Argentina and to implement and develop alternative methodologies applied to safety studies for regulatory purposes (NAM).
22-05251-299-23412

Thomas Hartung

Thomas Hartung, MD PhD, is professor at Johns Hopkins Bloomberg School of Public Health and the Whiting School of Engineering, Georgetown University, Washington D.C., and University of Konstanz, Germany; he also is Director of Centers for Alternatives to Animal Testing (CAAT) in the US and Europe and Field Chief Editor of Frontiers in AI. He authored 680+ scientific publications with 47,000+ citations (h-index 116) and his COURSERA toxicology classes had 19,000+ active learners.
Erin Hill

Erin Hill

Erin Hill is the President and CEO of ICCS with over 30 years of experience promoting animal-free safety testing methods. She co-founded the non-profit Institute for In Vitro Sciences (IIVS) and is actively involved in various boards and associations dedicated to reducing reliance on animal testing methods. Her contributions have earned her numerous awards and recognition.
SH23_0023datei2

Sebastian Hoffmann

Sebastian Hoffmann runs the independent consultancy ‘seh consulting + services‘, specialised in new approach methodologies (NAM) assessment and validation, evidence-based toxicology, and chemical regulation. His research focuses on enhancing the human relevance and transparency of safety and risk assessments through NAMs. He serves on the European Commission’s ECVAM Scientific Advisory Committee (ESAC) and the Board of Trustees for the Evidence-based Toxicology Collaboration (EBTC). Sebastian is a published author and frequent speaker at international conferences.
NK headshot 2023

Nicole Kleinstreuer

Dr. Nicole Kleinstreuer is the director of the US National Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM), and the executive director of the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM). Kleinstreuer leads domestic and international efforts to develop novel testing, modeling, and analysis strategies that provide more rapid, mechanistic, and human-relevant predictions of potential chemical hazards. She holds adjunct faculty positions in the Yale University School of Public Health and the University of North Carolina at Chapel Hill.
Afbeelding2

Elliot Lilley

Elliot Lilley is Programme Manager for the 3Rs in vaccine batch release and quality control testing at the UK National Centre for the 3Rs (NC3Rs). After 15-years in the pharmaceutical industry, Elliot spent 9 years with the RSPCA animals in research department where he worked to promote refinement. He joined the NC3Rs in 2020 to work on a project to apply the 3Rs to batch testing of biologics, working closely with the WHO and a working group of international experts. He is a Fellow of the British Pharmacological Society and animal ethics editor of the British Journal of Pharmacology.
Screenshot_20240529_082941_Photos

Paulo Abílio Lisboa

Researcher at the Institute of Science and Technology in Biomodels (ICTB/FIOCRUZ/RJ), Collaborating researcher at the Laboratory of Schistosomiasis and Zoonoses of the National School of Public Health (LCZ/DCB/ENSP/FIOCRUZ/RJ) Professor, Coordinator of the Discipline of Bioethics and Animal Welfare of the Specialization Course in Parasitic Biology and Biotechnology at the Oswaldo Cruz Institute (IOC/FIOCRUZ/RJ) Member of the One Health Commission of the Regional Council of Veterinary Medicine - RJ
Bianca

Bianca Marigliani

Senior principal strategist at the Humane Society International (HSI), Brazil. Biologist, holds postgraduate degrees in Molecular Biology, Systematic Review and Meta-analysis, master and PhD in Biotechnology. Winner of the 2015 Young Researcher Lush Prize, has more than a decade of experience in non-animal methods, dedicated to the end of animal exploitation in education, research, and testing, including the replacement of animal-derived products. Currently works in the HSI Research and Toxicology Department, focused on animal-free safety assessment and human-relevant approaches in biomedical research.
Gavin Maxwell 2022 Headshot

Gavin Maxwell

Dr Gavin Maxwell has 20 years of experience developing, evaluating, and applying non-animal approaches for safety assessment as part of Unilever’s Safety and Environmental Assurance Centre (SEAC). His immunology background and experience of using NAMs to inform NGRA decision-making, particularly for skin sensitisation, has led to his current role as Regulatory Science Strategy and Advocacy Lead, SEAC. Gavin is currently Industry co-chair of EPAA and vice chair of ICCS’s Core Acceptance Team.
foto ana carolina

Ana Carolina Migliorini Figueira

Coordinates the 3D Cultures and Microfluidics Laboratory at LNBio – CNPEM and also represents LNBio as a Central Laboratory associated with Alternative Methods Network - RENAMA. Since 2020, has focused her research on Tissue Engineering and regenerative medicine, developing reconstructed skin models, biological dressings, and 3D cultures and organ on a chip assay to be applied as new approaches methodologies - NAMs.
Afbeelding1

Yasuyuki Sakai

Yasuyuki SAKAI, Ph.D., is a professor at Department of Chemical System Engineering, University of Tokyo, Japan. He received his Ph.D. from University of Tokyo in 1993. He has been involved in JSAAE activity as the president (2015-2021) and for the establishment of Asian Federation of Societies of Alternatives to Animal Experiments (AFSAAE). His current research topics are development of microphysiological systems (MPS), engineering of implantable 3D tissues and large-scale stem cells culture.
Maren_schenke

Maren Schenke

Johns Hopkins University's Center for Alternatives to Animal Testing (CAAT), Baltimore, USA. Maren Schenke is a postdoctoral fellow at Johns Hopkins University's Center for Alternatives to Animal Testing (CAAT), with a background in biochemistry and _in vitro_ toxicology. She received her PhD from the University of Veterinary Medicine, in Hannover, Germany. Her current research focuses on developing human-relevant stem cell-derived neuronal models, emphasizing the integration of biological sex differences that influence neurodevelopment and neurotoxicology.
FOTOMPilarVinardell

Pilar Vinardell

Professor of Physiology at University of Barcelona. Her research has focused on the development and application of in vitro methods in ocular and dermal irritation, as well as dermal sensitization and photosensitization and Nanotoxicology. She is the author of over 200 articles and book chapters. Member of the OECD expert groups on dermal sensitization and ocular and dermal irritation. She has directed and taught several courses on the 3Rs.
A picture

Mathieu Vinken

Mathieu Vinken is a professor of toxicology with research focus on in vitro toxicology. He is author of 250 papers. He is editor-in-chief of Toxicology, associate editor of Archives of Toxicology and European editor of Applied In Vitro Toxicology. He coordinates several (inter)national toxicology projects, including the European Horizon 2020 project ONTOX. He is past-president of ESTIV, executive committee member of EUROTOX and founder of the EUROTOX In Vitro and In Silico Toxicology Speciality Section.
laura viviani foto

Laura Viviani

Founder of SciEthiQ, Italy. Since 2017, Laura has been working as consultant creating and leading global projects, many of them, dedicated to the implementation and regulatory acceptance of new non animal based assays in biologicals, including vaccines, and in general on supporting changes in the biomedical field. She collaborates with many international organizations, public and private institutions, and regulatory authorities globally. Before starting her consultancy activities, she managed projects in Novartis, GSK and Developing Countries Vaccine Manufacturers Network.
Kristina Wagner (1)

Kristina Wagner

Kristina Wagner is the head of the Animal Welfare Academy’s Department for animal-free science and has been with the German Animal Welfare Federation for over 15 years. In her role, she also represents the German Animal Welfare Federation in various alliances, working groups and committees. Kristina holds a degree in Biology from the Ludwig-Maximilians-University (Munich, Germany). She is passionate about life and nature and is dedicated to promote and support the transition to animal-free science.
Catherine-Willett-3

Kate Willett

ACT Board Member - Senior Director Science & Regulatory Affairs Humane Society International
Megan LaFollette 2021_Small Square Zoom

Megan LaFollette

Dr. Megan LaFollette is Executive Director at The 3Rs Collaborative, promoting better science for people and animals. She holds a PhD in Animal Behavior & Well-Being and a Master of Science in Animal Welfare from Purdue University. She has served on the International Society for Applied Ethology council and the AVMA’s Human-Animal Interaction Steering Committee. Her expertise includes rat tickling, compassion fatigue resiliency, and refined mouse handling, focusing on the 3Rs: refinement, reduction, and replacement.
Casey_Headshot

Warren Casey

Dr. Warren Casey is the Director of Strategic Partnerships in the Division of Translational Toxicology at the National Institute of Environmental Health Sciences. He manages collaborative programs promoting human-based testing approaches. He has held key leadership roles, including Executive Director of ICCVAM, Director of NICEATM, and President of the Society of Toxicology's In Vitro and Alternative Methods Specialty Section. Dr. Casey is Vice President of HESI and serves as a scientific advisor on various consortia.